Metsera Launches with Focus on Medicines for Obesity & Metabolic Diseases
Breaking News Advances a portfolio of oral and injectable incretin, non-incretin and combination therapies designed to address multiple targets. 04.18.24 Metsera Inc., a clinical-stage biopharmaceutical company accelerating medicines for obesity and …